Literature DB >> 17004135

Percutaneous interventional therapy of persistent biliary fistulas.

Baki Yagci1, Mustafa Parildar, Ismail Oran, Ahmet Memis.   

Abstract

BACKGROUND: Persistent biliary leakage is a challenging problem when conservative treatment methods fail. We present our experience with alternative percutaneous radiologic interventions to seal refractory biliary leaks.
METHODS: From April 1998 to December 2005, a retrospective analysis of 23 patients with biliary leakage revealed six patients who were unresponsive to drainage were treated with use of Histoacryl (n = 5), microcoils (n = 2), or covered stent (n = 2) alone or in various combinations.
RESULTS: In all patients, the biliary leakage ceased following a single procedure. Distally migration of microcoils into the abscess cavity was observed in a one coiling procedure, which was clinically insignificant. In one patient treated with covered stent, in-stent restenosis was seen in the postprocedural second year, which required another intervention. No recurrence of fistula was noted in the follow-up period (ranging from 6 to 47 months).
CONCLUSIONS: Persistent biliary fistulas can be treated successfully by means of various percutaneous radiological interventions that can decrease the morbidity associated with prolonged external drainage and avert the need for surgery. We recommend superselective embolization, preferably with Histoacryl, for a safe and effective control of leakage. Although restenosis after stenting remains problematic, covered stents should be reserved as a feasible alternative for selected cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17004135     DOI: 10.1007/s00261-006-9142-8

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  1 in total

1.  Surgical Management of Liver Hydatid Cyst Related Non-traumatic Emergencies: Single Center Experience.

Authors:  Tolga Dinc; Selami Ilgaz Kayilioglu; Okan Murat Akturk; Faruk Coskun
Journal:  Iran J Parasitol       Date:  2016 Oct-Dec       Impact factor: 1.012

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.